Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen K Wasan

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Pharmaceutics|June 28, 2002
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cellsEllen K Wasan, Dawn Waterhouse, Olena Sivak, et al.
Vaccine|February 12, 2019
A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in miceEllen K Wasan, Jaweria Syeda, Stacy Strom, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2010
Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009)Pavel Gershkovich, Olena Sivak, Ellen K Wasan, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2009
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulationPavel Gershkovich, Ellen K Wasan, Molly Lin, et al.
Journal of Pharmaceutical Sciences|November 11, 2009
The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivoBrian Banno, Ludger M Ickenstein, Gigi N C Chiu, et al.
Lipids in Health and Disease|August 10, 2011
Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse modelOlena Sivak, Pavel Gershkovich, Molly Lin, et al.
Molecular Pharmaceutics|March 18, 2022
Assessing the <i>In Vivo</i> Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen <i>Bordetella pertussis</i>Noorjahan Aibani, Parth Patel, Rachelle Buchanan, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|March 17, 2019
Investigation into spinal anesthetic failure with hyperbaric bupivacaine: the role of cold exposure on bupivacaine degradationEllen K Wasan, Calen Sacevich, Anas El-Aneed, et al.
Lipids in Health and Disease|August 23, 2011
In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell linesCarlos G Leon, Jinkyung Lee, Karen Bartlett, et al.
The Journal of Infectious Diseases|June 24, 2009
Highly effective oral amphotericin B formulation against murine visceral leishmaniasisKishor M Wasan, Ellen K Wasan, Pavel Gershkovich, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Pharmaceutics|June 28, 2002
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cellsEllen K Wasan, Dawn Waterhouse, Olena Sivak, et al.
Vaccine|February 12, 2019
A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in miceEllen K Wasan, Jaweria Syeda, Stacy Strom, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2010
Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009)Pavel Gershkovich, Olena Sivak, Ellen K Wasan, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2009
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulationPavel Gershkovich, Ellen K Wasan, Molly Lin, et al.
Journal of Pharmaceutical Sciences|November 11, 2009
The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivoBrian Banno, Ludger M Ickenstein, Gigi N C Chiu, et al.
Lipids in Health and Disease|August 10, 2011
Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse modelOlena Sivak, Pavel Gershkovich, Molly Lin, et al.
Molecular Pharmaceutics|March 18, 2022
Assessing the <i>In Vivo</i> Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen <i>Bordetella pertussis</i>Noorjahan Aibani, Parth Patel, Rachelle Buchanan, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|March 17, 2019
Investigation into spinal anesthetic failure with hyperbaric bupivacaine: the role of cold exposure on bupivacaine degradationEllen K Wasan, Calen Sacevich, Anas El-Aneed, et al.
Lipids in Health and Disease|August 23, 2011
In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell linesCarlos G Leon, Jinkyung Lee, Karen Bartlett, et al.
The Journal of Infectious Diseases|June 24, 2009
Highly effective oral amphotericin B formulation against murine visceral leishmaniasisKishor M Wasan, Ellen K Wasan, Pavel Gershkovich, et al.
Pageof 4